- PMID 15569934.
Velcheti V,
Schalper KA,
Carvajal DE,
Anagnostou VK,
Syrigos KN,
Sznol M, et al. (January 2014). "Programmed
death ligand-1
expression in non-small...
- Jure-Kunkel M,
Agrawal S,
McDonald D,
Kollia GD,
Gupta A,
Wigginton JM,
Sznol M (June 2012). "Safety, activity, and
immune correlates of anti-PD-1 antibody...
- Jure-Kunkel M,
Agrawal S,
McDonald D,
Kollia GD,
Gupta A,
Wigginton JM,
Sznol M (June 2012). "Safety, activity, and
immune correlates of anti-PD-1 antibody...
- Maria; Maki,
Robert G.; Rodriguez-Galindo, Carlos; Schilsky,
Richard L.;
Sznol, Mario; Westin,
Shannon Neville; Burstein,
Harold (April 2018). "Clinical...
- Chen Y, Zhu G, Yin W,
Zheng L, Zhou T,
Badri T, Yao S, Zhu S, Boto A,
Sznol M,
Melero I,
Vignali DA,
Schalper K, Chen L (Jan 2019). "Fibrinogen-like...
- Wolchok, MD, PhD -
Memorial Sloan Kettering Cancer Center Immediate Past President:
Mario Sznol, MD - Yale
School of
Medicine Website www.sitcancer.org...
- KB,
Boasberg PD,
Simantov R,
Crowley E,
Green JA,
Hawthorne T,
Davis TA,
Sznol M, Hwu P (2014-11-10). "Phase I/II
Study of the Antibody-Drug Conjugate...
-
Ariyan S,
Narayan D, Dutton-Regester K,
Capatana A,
Holman EC,
Bosenberg M,
Sznol M,
Kluger HM,
Brash DE,
Stern DF,
Materin MA, Lo RS, Mane S, Ma S, Kidd...
- the Dana–Farber
Cancer Institute in Boston. Hoos A,
Parmiani G, Hege K,
Sznol M,
Loibner H,
Eggermont A, Urba W,
Blumenstein B,
Sacks N,
Keilholz U, Nichol...
-
Ariyan S,
Narayan D, Dutton-Regester K,
Capatana A,
Holman EC,
Bosenberg M,
Sznol M,
Kluger HM,
Brash DE,
Stern DF,
Materin MA, Lo RS, Mane S, Ma S, Kidd...
